cDNA . | 3′ RACE forward primer . | Product size (bp) . | 5′ RACE reverse primer . | Product size (bp) . |
---|---|---|---|---|
MyoD | AGATGCACGTCCACCAACCCGAACC | 1143 | AAGGATCCCCACTTTGGGCAGCCTCTGG | 512 |
α-actin | ACCTTCCAGCAGATGTGGATCAGCA | 494 | AAGCACTTCCTGTGGACGATGGAGG | 1194 |
MyHC | CAAGGAGCAGGCTGCTATGGTTGAGC | 934 | ||
TnT | CCAAGCAGCAGAAGGGCCCGTT | 447 | ||
TnI | GATGAGGAGCGGTACGATGCTGCGG | 516 | GCAGACATGCGCACCTTCTTCAGGG | 447 |
CK-M | GGTGGCGATGACCTGGACCCC | 1205 | ||
TnC | TGCATCAGTACCAAGGA | 606 |
cDNA . | 3′ RACE forward primer . | Product size (bp) . | 5′ RACE reverse primer . | Product size (bp) . |
---|---|---|---|---|
MyoD | AGATGCACGTCCACCAACCCGAACC | 1143 | AAGGATCCCCACTTTGGGCAGCCTCTGG | 512 |
α-actin | ACCTTCCAGCAGATGTGGATCAGCA | 494 | AAGCACTTCCTGTGGACGATGGAGG | 1194 |
MyHC | CAAGGAGCAGGCTGCTATGGTTGAGC | 934 | ||
TnT | CCAAGCAGCAGAAGGGCCCGTT | 447 | ||
TnI | GATGAGGAGCGGTACGATGCTGCGG | 516 | GCAGACATGCGCACCTTCTTCAGGG | 447 |
CK-M | GGTGGCGATGACCTGGACCCC | 1205 | ||
TnC | TGCATCAGTACCAAGGA | 606 |
. | RT-PCR analysis primers . | . | . | |
---|---|---|---|---|
cDNA . | Forward . | Reverse . | Product size (bp) . | |
MyoD | GAGCCTTGGTCGAACATCACCGAC | GGAACTTTGATGAGCTTGCTTCTTATCAG | 1262 | |
L15 | GCTCCCAGACCCACCAGACCC | ATGGCCTTGTGGAAGGTGTCG | 311 |
. | RT-PCR analysis primers . | . | . | |
---|---|---|---|---|
cDNA . | Forward . | Reverse . | Product size (bp) . | |
MyoD | GAGCCTTGGTCGAACATCACCGAC | GGAACTTTGATGAGCTTGCTTCTTATCAG | 1262 | |
L15 | GCTCCCAGACCCACCAGACCC | ATGGCCTTGTGGAAGGTGTCG | 311 |
MyoD, Myogenic determination factor; α-actin,skeletal α-actin; MyHC, myosin heavy chain; TnT,troponin T; TnI, troponin I; CK-M, muscle creatine kinase; TnC, troponin C
RACE, rapid amplification of cDNA ends; RT-PCR, reverse transcriptase-polymerase chain reaction. For details, see Materials and methods
Final product sizes calculated include the primer sequences
Clones used for in situ hybridization